Chief Executive Officer
Dr. Douville is an entrepreneurial executive with a track record of success in starting up biotech companies. Dr. Douville co-founded Galileo Genomics (now Genizon Biosciences) a population genetics company. As founding CEO, he negotiated GalileoвЂ™s seminal strategic alliance with Myriad Genetics and subsequently, as Chief Business Officer, he played a key role in preparing the company for its Series A financing. After leaving Galileo, Dr. Douville has been involved in conceptualizing and building Milestone Pharmaceuticals leading to its first round of financing in 2006/2007. Dr. Douville obtained his Ph.D. in neurosciences from McGill University in 1991 and subsequently pursued research activities at the University of Zurich, Switzerland.